94 related articles for article (PubMed ID: 26927018)
21. Synthesis and hepatitis C antiviral activity of 1-aminobenzyl-1H-indazole-3-carboxamide analogues.
Shi JJ; Ji FH; He PL; Yang YX; Tang W; Zuo JP; Li YC
ChemMedChem; 2013 May; 8(5):722-5. PubMed ID: 23512654
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of indazole based diarylurea derivatives and their antiproliferative activity against tumor cell lines.
Zhao CR; Wang RQ; Li G; Xue XX; Sun CJ; Qu XJ; Li WB
Bioorg Med Chem Lett; 2013 Apr; 23(7):1989-92. PubMed ID: 23454017
[TBL] [Abstract][Full Text] [Related]
23. Discovery of a new HIV-1 inhibitor scaffold and synthesis of potential prodrugs of indazoles.
Kim SH; Markovitz B; Trovato R; Murphy BR; Austin H; Willardsen AJ; Baichwal V; Morham S; Bajji A
Bioorg Med Chem Lett; 2013 May; 23(10):2888-92. PubMed ID: 23566519
[TBL] [Abstract][Full Text] [Related]
24. Himbacine derived thrombin receptor (PAR-1) antagonists: structure-activity relationship of the lactone ring.
Xia Y; Chackalamannil S; Chan TM; Czarniecki M; Doller D; Eagen K; Greenlee WJ; Tsai H; Wang Y; Ahn HS; Boykow GC; McPhail AT
Bioorg Med Chem Lett; 2006 Sep; 16(18):4969-72. PubMed ID: 16824760
[TBL] [Abstract][Full Text] [Related]
25. Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases.
McBride CM; Renhowe PA; Heise C; Jansen JM; Lapointe G; Ma S; Piñeda R; Vora J; Wiesmann M; Shafer CM
Bioorg Med Chem Lett; 2006 Jul; 16(13):3595-9. PubMed ID: 16603352
[TBL] [Abstract][Full Text] [Related]
26. Discovery of (R)-1-(7-chloro-2,2-bis(fluoromethyl)chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea (A-1165442): a temperature-neutral transient receptor potential vanilloid-1 (TRPV1) antagonist with analgesic efficacy.
Voight EA; Gomtsyan AR; Daanen JF; Perner RJ; Schmidt RG; Bayburt EK; DiDomenico S; McDonald HA; Puttfarcken PS; Chen J; Neelands TR; Bianchi BR; Han P; Reilly RM; Franklin PH; Segreti JA; Nelson RA; Su Z; King AJ; Polakowski JS; Baker SJ; Gauvin DM; Lewis LR; Mikusa JP; Joshi SK; Faltynek CR; Kym PR; Kort ME
J Med Chem; 2014 Sep; 57(17):7412-24. PubMed ID: 25100568
[TBL] [Abstract][Full Text] [Related]
27. Novel quinazoline-urea analogues as modulators for Aβ-induced mitochondrial dysfunction: design, synthesis, and molecular docking study.
Elkamhawy A; Lee J; Park BG; Park I; Pae AN; Roh EJ
Eur J Med Chem; 2014 Sep; 84():466-75. PubMed ID: 25050879
[TBL] [Abstract][Full Text] [Related]
28. New hypotheses for the binding mode of 4- and 7-substituted indazoles in the active site of neuronal nitric oxide synthase.
Lohou E; Sopkova-de Oliveira Santos J; Schumann-Bard P; Boulouard M; Stiebing S; Rault S; Collot V
Bioorg Med Chem; 2012 Sep; 20(17):5296-304. PubMed ID: 22831803
[TBL] [Abstract][Full Text] [Related]
29. Discovery of indazoles as inhibitors of Tpl2 kinase.
Hu Y; Cole D; Denny RA; Anderson DR; Ipek M; Ni Y; Wang X; Thaisrivongs S; Chamberlain T; Hall JP; Liu J; Luong M; Lin LL; Telliez JB; Gopalsamy A
Bioorg Med Chem Lett; 2011 Aug; 21(16):4758-61. PubMed ID: 21742493
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and insight into the structure-activity relationship of 1,3-disubstituted indazoles as novel HIF-1 inhibitors.
An H; Kim NJ; Jung JW; Jang H; Park JW; Suh YG
Bioorg Med Chem Lett; 2011 Nov; 21(21):6297-300. PubMed ID: 21937231
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antiviral activity of P1' arylsulfonamide azacyclic urea HIV protease inhibitors.
Huang PP; Randolph JT; Klein LL; Vasavanonda S; Dekhtyar T; Stoll VS; Kempf DJ
Bioorg Med Chem Lett; 2004 Aug; 14(15):4075-8. PubMed ID: 15225729
[TBL] [Abstract][Full Text] [Related]
32. Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management.
Gomtsyan A; Bayburt EK; Schmidt RG; Surowy CS; Honore P; Marsh KC; Hannick SM; McDonald HA; Wetter JM; Sullivan JP; Jarvis MF; Faltynek CR; Lee CH
J Med Chem; 2008 Feb; 51(3):392-5. PubMed ID: 18183945
[TBL] [Abstract][Full Text] [Related]
33. Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas.
Ng EW; Aung MM; Abood ME; Martin BR; Razdan RK
J Med Chem; 1999 Jun; 42(11):1975-81. PubMed ID: 10354405
[TBL] [Abstract][Full Text] [Related]
34. SCH-530348, a thrombin receptor (PAR-1) antagonist for the prevention and treatment of atherothrombosis.
Oestreich J
Curr Opin Investig Drugs; 2009 Sep; 10(9):988-96. PubMed ID: 19705342
[TBL] [Abstract][Full Text] [Related]
35. Analgesic potential of TRPV1 antagonists.
Kym PR; Kort ME; Hutchins CW
Biochem Pharmacol; 2009 Aug; 78(3):211-6. PubMed ID: 19481638
[TBL] [Abstract][Full Text] [Related]
36. Novel C-3 N-urea, amide, and carbamate dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole analogs as potent TIE-2 and VEGF-R2 dual inhibitors.
Becknell NC; Zulli AL; Angeles TS; Yang S; Albom MS; Aimone LD; Robinson C; Chang H; Hudkins RL
Bioorg Med Chem Lett; 2006 Oct; 16(20):5368-72. PubMed ID: 16890434
[TBL] [Abstract][Full Text] [Related]
37. Exploration of a new series of PAR1 antagonists.
Planty B; Pujol C; Lamothe M; Maraval C; Horn C; Le Grand B; Perez M
Bioorg Med Chem Lett; 2010 Mar; 20(5):1735-9. PubMed ID: 20137929
[TBL] [Abstract][Full Text] [Related]
38. Piperazine imidazo[1,5-a]quinoxaline ureas as high-affinity GABAA ligands of dual functionality.
Jacobsen EJ; Stelzer LS; TenBrink RE; Belonga KL; Carter DB; Im HK; Im WB; Sethy VH; Tang AH; VonVoigtlander PF; Petke JD; Zhong WZ; Mickelson JW
J Med Chem; 1999 Apr; 42(7):1123-44. PubMed ID: 10197957
[TBL] [Abstract][Full Text] [Related]
39. 3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6.
Fraley ME; Steen JT; Brnardic EJ; Arrington KL; Spencer KL; Hanney BA; Kim Y; Hartman GD; Stirdivant SM; Drakas BA; Rickert K; Walsh ES; Hamilton K; Buser CA; Hardwick J; Tao W; Beck SC; Mao X; Lobell RB; Sepp-Lorenzino L; Yan Y; Ikuta M; Munshi SK; Kuo LC; Kreatsoulas C
Bioorg Med Chem Lett; 2006 Dec; 16(23):6049-53. PubMed ID: 16978863
[TBL] [Abstract][Full Text] [Related]
40. A novel series of indazole-/indole-based glucagon receptor antagonists.
Lin S; Zhang F; Jiang G; Qureshi SA; Yang X; Chicchi GG; Tota L; Bansal A; Brady E; Trujillo M; Salituro G; Miller C; Tata JR; Zhang BB; Parmee ER
Bioorg Med Chem Lett; 2015 Oct; 25(19):4143-7. PubMed ID: 26303893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
